Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U3GL
|
|||
| Former ID |
DAP000905
|
|||
| Drug Name |
Oxandrolone
|
|||
| Synonyms |
Anavar; Lonavar; Ossandrolone; Oxandrin; Oxandrolona; Oxandrolonum; Protivar; Provitar; Vasorome; Ossandrolone [DCIT]; SC 11585; Anavar (TN); Oxandrin (TN); Oxandrolona [INN-Spanish]; Oxandrolonum [INN-Latin]; SC-11585; Oxandrin, Anavar, Oxandrolone; Oxandrolone (JAN/USP/INN); Oxandrolone [USAN:INN:BAN:JAN]; Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone; (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one; (4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one; 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one; 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI); 17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one; 17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one; 2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-(8CI); 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-(9CI)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alcoholic hepatitis [ICD-11: DB94.1; ICD-10: K70.1; ICD-9: 571.1] | Approved | [1], [2] | |
| Company |
Pfizer Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H30O3
|
|||
| Canonical SMILES |
CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
|
|||
| InChI |
1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1
|
|||
| InChIKey |
QSLJIVKCVHQPLV-PEMPUTJUSA-N
|
|||
| CAS Number |
CAS 53-39-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9553, 7847528, 7980213, 8153633, 14751988, 14776396, 29224905, 46509027, 48416358, 49833409, 49999542, 56310882, 56313001, 56352998, 57323011, 71821462, 78468418, 92713867, 103770419, 104253360, 104310507, 119525274, 124757478, 125164282, 126629716, 126665869, 129068737, 134222231, 134338182, 134971185, 137003785, 140181114, 160963966, 170506535, 175266129, 175611735, 176485087, 178103670, 179117105, 196110073, 210279824, 210282147, 223672704, 223813099, 226514498, 241093246, 252159083, 252220166, 252451761
|
|||
| ChEBI ID |
CHEBI:7820
|
|||
| ADReCS Drug ID | BADD_D01634 | |||
| SuperDrug ATC ID |
A14AA08
|
|||
| SuperDrug CAS ID |
cas=000053394
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7092). | |||
| REF 2 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076761. | |||
| REF 3 | The effect of oxandrolone treatment on human osteoblastic cells. J Burns Wounds. 2007 Mar 7;6:e4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.